Literature DB >> 21364345

Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.

Sebastian Walther, Brigitte Schüpbach, Erich Seifritz, Philipp Homan, Werner Strik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21364345     DOI： 10.1097/JCP.0b013e31820e861c

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  28 in total

Review 1.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

2.  Nabilone for the Treatment of Dementia-Associated Sexual Disinhibition.

Authors:  Daria M Zajac; Sarah R Sikkema; Ranjith Chandrasena
Journal:  Prim Care Companion CNS Disord       Date:  2015-02-19

3.  Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.

Authors:  Geke A H van den Elsen; Amir I A Ahmed; Robbert-Jan Verkes; Cees Kramers; Ton Feuth; Paul B Rosenberg; Marjolein A van der Marck; Marcel G M Olde Rikkert
Journal:  Neurology       Date:  2015-05-13       Impact factor: 9.910

Review 4.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

Review 5.  Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia.

Authors:  Mehnaz Ahmed; Marlene Malik; Johannes Teselink; Krista L Lanctôt; Nathan Herrmann
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 6.  Cannabinoids for the treatment of dementia.

Authors:  Dina Bosnjak Kuharic; Domagoj Markovic; Tonci Brkovic; Milka Jeric Kegalj; Zana Rubic; Ana Vuica Vukasovic; Ana Jeroncic; Livia Puljak
Journal:  Cochrane Database Syst Rev       Date:  2021-09-17

7.  Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis.

Authors:  Anees Bahji; Arthi Chinna Meyyappan; Emily R Hawken
Journal:  Can J Psychiatry       Date:  2019-12-13       Impact factor: 4.356

8.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2020-11-15

9.  Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.

Authors:  Amir I A Ahmed; Geke A H van den Elsen; Angela Colbers; Cornelis Kramers; David M Burger; Marjolein A van der Marck; Marcel G M Olde Rikkert
Journal:  Psychopharmacology (Berl)       Date:  2015-03-11       Impact factor: 4.530

Review 10.  Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

Authors:  Katherine A Belendiuk; Lisa L Baldini; Marcel O Bonn-Miller
Journal:  Addict Sci Clin Pract       Date:  2015-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.